
Sign up to save your podcasts
Or


From clot to clear flow, minimally invasive aspiration devices are PAVE-ing the way for safer treatment of endocarditis and cardiac masses. In this BackTable Cardiology episode, host Dr. Hady Lichaa sits down with Dr. Abdallah El Sabbagh to discuss percutaneous continuous-flow aspiration for right- and select left-sided endocarditis and cardiac masses.
---
Get the BackTable app
https://www.backtable.com/app
---
This podcast is supported by
Angiodynamics
https://9zfaiv.short.gy/cardiovascular-backtable
---
Timestamps
00:00 - Introduction
03:43 - Lessons in Fibroelastoma
12:01 - Imaging Workup
14:24 - Transesophageal Echocardiography (TEE) vs Intracardiac Echocardiography (ICE)
17:52 - AngioVac System Components
20:33 - Access Strategy, Sheath Size and Flow Rates
23:41 - Adjunct Tools and Retrieval Options
31:35 - Using Continuous Aspiration
47:16 - Percutaneous AngioVac Vegetation Extraction (PAVE) Trial
53:17 - Future Devices Wishlist
---
More about this episode
Dr. El Sabbagh provides guidance on removing papillary fibroelastomas, emphasizing matching technique to mass characteristics and combining tools such as continuous aspiration with electrosurgical snaring to address adherent stalks. Their conversation covers patient selection for off-label endocarditis intervention, including intravenous drug use and Cardiac Implantable Electronic Device (CIED) lead infections, use of aspiration as definitive therapy, and imaging/workflow preferences. Dr. El Sabbagh details the AngioVac system, access strategies, adjunct devices, mitigating complications, and registry outcomes. He touches on the need for prospective studies, including the Percutaneous AngioVac Vegetation Extraction (PAVE) clinical trial. To finish the conversation, Drs. Lichaa and El Sabbagh look ahead to building future devices and provide advice on creating multidisciplinary programs as well as training pathways.
---
Resources
Dr. Hady Lichaa’s Provider Profile
https://healthcare.ascension.org/find-care/provider/1336267533/hady-lichaa
Dr. Abdallah El Sabbagh’s Provider Profile
https://www.mayoclinic.org/biographies/el-sabbagh-abdallah-m-d/bio-20466764
Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective Endocarditis - PAVE Clinical Trial
https://clinicaltrials.gov/study/NCT07282002
---
BackTable Cardiology is the go-to podcast for interventional cardiologists, cardiac surgeons, and other healthcare professionals that manage cardiovascular conditions.
Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.
► https://www.backtable.com/app
By BackTable Inc.From clot to clear flow, minimally invasive aspiration devices are PAVE-ing the way for safer treatment of endocarditis and cardiac masses. In this BackTable Cardiology episode, host Dr. Hady Lichaa sits down with Dr. Abdallah El Sabbagh to discuss percutaneous continuous-flow aspiration for right- and select left-sided endocarditis and cardiac masses.
---
Get the BackTable app
https://www.backtable.com/app
---
This podcast is supported by
Angiodynamics
https://9zfaiv.short.gy/cardiovascular-backtable
---
Timestamps
00:00 - Introduction
03:43 - Lessons in Fibroelastoma
12:01 - Imaging Workup
14:24 - Transesophageal Echocardiography (TEE) vs Intracardiac Echocardiography (ICE)
17:52 - AngioVac System Components
20:33 - Access Strategy, Sheath Size and Flow Rates
23:41 - Adjunct Tools and Retrieval Options
31:35 - Using Continuous Aspiration
47:16 - Percutaneous AngioVac Vegetation Extraction (PAVE) Trial
53:17 - Future Devices Wishlist
---
More about this episode
Dr. El Sabbagh provides guidance on removing papillary fibroelastomas, emphasizing matching technique to mass characteristics and combining tools such as continuous aspiration with electrosurgical snaring to address adherent stalks. Their conversation covers patient selection for off-label endocarditis intervention, including intravenous drug use and Cardiac Implantable Electronic Device (CIED) lead infections, use of aspiration as definitive therapy, and imaging/workflow preferences. Dr. El Sabbagh details the AngioVac system, access strategies, adjunct devices, mitigating complications, and registry outcomes. He touches on the need for prospective studies, including the Percutaneous AngioVac Vegetation Extraction (PAVE) clinical trial. To finish the conversation, Drs. Lichaa and El Sabbagh look ahead to building future devices and provide advice on creating multidisciplinary programs as well as training pathways.
---
Resources
Dr. Hady Lichaa’s Provider Profile
https://healthcare.ascension.org/find-care/provider/1336267533/hady-lichaa
Dr. Abdallah El Sabbagh’s Provider Profile
https://www.mayoclinic.org/biographies/el-sabbagh-abdallah-m-d/bio-20466764
Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective Endocarditis - PAVE Clinical Trial
https://clinicaltrials.gov/study/NCT07282002
---
BackTable Cardiology is the go-to podcast for interventional cardiologists, cardiac surgeons, and other healthcare professionals that manage cardiovascular conditions.
Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.
► https://www.backtable.com/app